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Abstract
Background: Metabolic syndrome (MetS) encompasses a cluster of coronary heart disease and diabetes mellitus risk 
factors. In this study, we aimed to elucidate the factors underlying the clustering of MetS components in diabetic and 
non-diabetic individuals.
Methods: Factor analysis was performed on 2978 (1652 non-diabetic and 1326 diabetic) participants. Entering waist 
circumference, homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides, high-density lipoprotein-
cholesterol (HDL-C) and systolic blood pressure (SBP), we performed exploratory factor analysis in diabetic and non-
diabetic individuals separately. The analysis was repeated after replacing triglycerides and HDL-C with triglycerides to 
HDL-C ratio (triglycerides/HDL-C). MetS was defined by either adult treatment panel III (ATPIII), international diabetes 
federation (IDF) criteria, or by the modified form of IDF using waist circumference cut-off points for Iranian population.
Results: The selection of triglycerides and HDL-C as two distinct variables led to identifying two factors explaining 
61.3% and 55.4% of the total variance in non-diabetic and diabetic participants, respectively. In both diabetic and non-
diabetic subjects, waist circumference, HOMA-IR and SBP loaded on factor 1. Factor 2 was mainly determined by 
triglycerides and HDL-C. Factor 1 and 2 were directly and inversely associated with MetS, respectively. When 
triglycerides and HDL-C were replaced by triglycerides/HDL-C, one factor was extracted, which explained 47.6% and 
38.8% of the total variance in non-diabetic and diabetic participants, respectively.
Conclusion: This study confirms that in both diabetic and non-diabetic participants the concept of a single underlying 
factor representing MetS is plausible.
Background
Metabolic syndrome (MetS) encompasses a cluster of
coronary heart disease and diabetes mellitus risk factors,
including abdominal obesity, glucose intolerance, dyslipi-
demia and elevated blood pressure [1,2]. Subjects with
MetS tend to have high insulin levels, reflecting greater
insulin resistance [1-3]. Insulin resistance or hyperinsu-
linemia has been suggested to be the underlying charac-
teristic of MetS, although a central role for insulin
resistance is still controversial [3]. The understanding of
how MetS components cluster together can help clini-
cians interpret the MetS pathophysiology and develop
effective strategies for identifying and preventing the
inherent risk of coronary heart disease and diabetes mel-
litus. The multitude of clinical and biochemical altera-
tions resembling the MetS, the strong cross-linkage of
involved pathways and multiple feedback mechanisms,
complicate the identification of the events which lead to
the cascade of disorders that characterize the syndrome
[4]. Moreover, statistically strong intercorrelations among
various features of MetS, also complicate establishing
independent associations using standard multivariate sta-
tistical models [2,3]. Factor analysis is potentially a way of
advancing this body of research by explaining the correla-
tion between the components of the syndrome in terms
of a small set of latent factors, providing insights into the
underlying process. Exploratory factor analysis is a
hypotheses generation method, in which the number of
factors is essentially unknown and has to be determined
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from data. Extracting one factor implies that a single
underlying pathophysiologic mechanism contributes to
the appearance of the syndrome. If two or more factors
were extracted, the existence of a unique syndrome
would be called into question [3].
Previous studies have entered different numbers of
variables ranged from 4 to 21 in factor analysis and
extracted from 1 to 7 factors [2,5-13]. Some investiga-
tions have identified three or four factors, implying a pos-
sible heterogeneity of the MetS [2,7,9-11]. Since there
appears to be ethnic differences in the expression of MetS
[1], different findings may arise on the basis of sample
collection. For example, hypertension may not be associ-
ated with MetS in American Indians and African Ameri-
cans [14]. Variations in the extracted factors can also be
result of discrepancies in numbers and nature of consid-
ered components. For example some studies include
insulin levels while others do not; the same is true for uric
acid, leptin and waist to hip ratio [2,5-13]. Since factor
analysis extracts factors due to the interrelatedness of
measured variables, using two or more measures for the
same trait (e.g. systolic blood pressure [SBP] and diastolic
blood pressure [DBP]) leads to find more factors than
expected [15]. These variables compared to other vari-
ables are highly associated with each other, thus tend to
load on a separate factor. This phenomenon can also be
observed with fasting and postprandial glucose or with
high density lipoprotein cholesterol (HDL-C) and triglyc-
erides (TG) [5,16].
Factor analysis of the MetS has been the focus of little
attention in the Middle Eastern ethnicity; furthermore,
t h e  c l u s t e r i n g  o f  M e t S  c o m p o n e n t s  i s  y e t  t o  b e  m o r e
explored in the diabetic patients. In this study, for the first
time we performed factor analysis on the components of
MetS in a large sample of Iranian diabetic and non-dia-
betic participants. MetS can be defined according to
Adult Treatment Panel (ATPIII) [1] or International Dia-
betes Federation (IDF) criteria [17]. We recently pro-
posed that the optimal waist circumference cut-off points
for the diagnosis of IDF defined MetS in Iranian adults
would be different from those of other populations [18].
I n  t h i s  s t u d y ,  w e  a l s o  e x p l o r e d  t h e  i n f l u e n c e  o f  t h e
extracted factors on different definitions of MetS.
Methods
Participants
A total of 3023 participants (aged 18-75 yrs), who were
referred consecutively from September 2005 to Decem-
ber 2008 to one of the four Tehran University-affiliated
health service centers located in east, west, south and
center of Tehran, were studied. Participants were enrolled
from individuals taking health examinations, or those
who accompanied patients. Subjects who needed special
concern beyond routine examination for their symptoms
(i.e. patients with chronic liver disease, renal, thyroid or
adrenal problems) along with those under insulin therapy
were not included in the study. Diabetic participants were
taking metformin, glibenclamide or both simultaneously
for controlling their hyperglycemia. Due to missing data,
45 participants were excluded, resulting in a total of 2978
subjects. Oral informed consent was obtained from all
individuals before study commencement. The study was
conducted in accordance with Helsinki declaration and
was performed in line with considerations, recom-
mended by local ethics review committee of Tehran Uni-
versity of Medical Sciences.
Procedures
Waist circumference was measured at mid-distance
between iliac crest and rib cage and was rounded to the
nearest 0.1 cm. The participants were instructed to rest
for at least 5 min before having their blood pressure
checked twice with at least 5 min interval. Venous blood
samples were collected following 12 h overnight fast.
Fasting plasma glucose was measured by glucose-oxidase
method. TG and HDL-C were determined by enzymatic
methods (Parsazmun, Karaj, Iran). Insulin was measured
by radioimmunoassay, using an antibody with no cross-
reaction against pro-insulin and C-peptide (Immunotech,
Prague, Czech Republic). The intra and inter-assay coeffi-
cients of variation were lower than 4.3 and 3.4, respec-
tively.
Definitions
The homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated as fasting insulin (U/l) × fast-
ing plasma glucose (mg/dl)/405, as described by Mat-
thews et al. [19]. Diabetes mellitus was diagnosed
according to the criteria of American Diabetes Associa-
tion [20]. The average of two obtained SBPs was used in
this study. MetS was defined due to either original ATPIII
or IDF declarations. ATPIII criteria allow the diagnosis of
MetS when three or more of the following conditions are
satisfied: presence of the abdominal obesity (waist cir-
cumference ≥102 cm and ≥88 cm in men and women,
respectively), elevated blood pressure (SBP ≥130 mmHg
and/or DBP ≥85 mmHg), low HDL-C (<40 mg/dl and <50
mg/dl in men and women, respectively), TG ≥150 mg/dl
and fasting plasma glucose ≥100 mg/dl (or diabetes)
[1,21]. According to original IDF criteria a person with
MetS must have abdominal obesity (waist circumference
≥94 cm and ≥80 cm in men and women, respectively)
plus any two or more of the following conditions: ele-
vated blood pressure (see above) or treatment of previ-
ously diagnosed hypertension, low HDL-C (see above) or
on HDL-C therapy, TG ≥150 mg/dl or on TG therapy and
fasting plasma glucose ≥100 mg/dl (or diabetes) [17].
MetS was also defined by the modified form of IDF crite-Esteghamati et al. Diabetology & Metabolic Syndrome 2010, 2:36
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ria in which the waist circumference cut-offs were substi-
tuted by optimal values (waist circumference ≥90 cm in
both men and women) for use in Iranian population [18].
Statistical analysis
Da ta wer e analyzed using S PSS software (version 16.0;
SPSS Inc., Chicago, USA). To extrapolate our results to
the population of Tehran we carried out a complex sam-
ple survey analysis. The data were directly weighted for
age (10-year strata) and sex distribution of diabetic and
non-diabetic residents of Tehran, according to the results
of an epidemiological study on patterns of diabetes, con-
ducted by the Ministry of Health [22], and the data of the
national censuses of Iran in 2006. To compare the princi-
pal characteristics of diabetic and non-diabetic partici-
pants, we used the method of general linear modeling in
complex sample analysis mode using the F statistic. Com-
parisons for categorical variables were made by design-
based χ2 analysis. The relationship between individual
variables was examined using bivariate Pearson's correla-
tion coefficients. Since a large number of analyses were
carried out, a P <0.01 was considered statistically signifi-
cant. In order to improve the normality of skewed vari-
ables (i.e. HOMA-IR, TG and TG to HDL-C ratio) natural
log transformations were used in the subsequent analyses
as appropriate. Factor analysis was performed in two sep-
arate models. In model 1 waist circumference, SBP,
HOMA-IR, TG and HDL-C were selected for analyses.
Exploratory factor analysis was performed using princi-
pal component analysis, a technique for reducing the
number of original variables into fewer latent factors. The
variables cluster on the basis of linear correlations that
exist among them. Factors with an eigenvalue (the
amount of variance attributable to the factor) of greater
than one were extracted and transformed by varimax
rotation method to enhance interpretation. Varimax
method maintains the independence of extracted factors
and simplifies the interpretation of analysis by maximiz-
ing factor loadings to one or minimizing it to zero. Vari-
max rotation cannot be performed if factor analysis
extracts just one factor. Factor scores, which are estimates
of individual factors with the mean and standard devia-
tion equal to 0 and 1, respectively, were determined by
regression method. The factor loading of a variable on a
factor equals the correlation coefficient between that
variable and the factor score. In accordance with several
previous reports, factor loadings of ≥|0.40| were consid-
ered meaningful for interpretation; because this ensures
that the variable shares at least 15% of the variance with
the factor [2, 6, 8, 9, 11-13, 15]. Factor analysis was per-
formed in diabetic and non-diabetic participants sepa-
rately. Binary logistic regression analysis was used to
assess the association of factor scores with MetS defined
by either ATPIII or original IDF or by the modified form
of IDF criteria.
Considering that two of the variables entered in analy-
ses are related to lipid profile (i.e. TG and HDL-C), in
model 2 we repeated all aforementioned analyses after
substituting ratio of TG to HDL-C for both TG and HDL-
C.
Results
Descriptive statistics
Sex-specific principal characteristics of our study popula-
tion in diabetic and non-diabetic participants are pre-
s e n t e d  i n  T a b l e  1 .  I n  m e n  t h e  m e a n  a g e s  ±  S E M  o f
diabetic and non-diabetic participants were 53.8 ± 0.5
and 41.1 ± 0.7 years and in women were 54.1 ± 0.4 and
40.0 ± 0.4 years, respectively. There were significant dif-
ferences between all variables mentioned in Table 1,
except insulin concentration. After adjusting for age and
sex, in diabetic participants the prevalence of MetS
defined by ATPIII, original IDF and modified IDF criteria
(74%, 76% and 69%, respectively) was higher than non-
diabetic participants (33%, 37%.and 32%, respectively, P
<0.001)
Univariate associations
In non-diabetic participants, all variables entered in anal-
ysis were correlated with each other except HDL-C and
SBP. However, in diabetic participants, SBP was merely
associated with waist circumference (Table 2).
Exploratory factor analysis and logistic regression
Entering waist circumference, HOMA-IR, TG, HDL-C
and SBP as variables (components of MetS) in model 1,
exploratory factor analysis extracted two factors in both
non-diabetic and diabetic participants (Table 3 and Fig-
ure 1). Generally, factor 1 was related to waist circumfer-
ence, HOMA-IR and SBP while factor 2 was mainly
determined by TG and HDL-C (Table 3). In non-diabetic
participants TG also loaded positively on factor 1. HDL-
C loaded positively and TG negatively on factor 2. These
two factors together explained 61.3% and 55.4% of the
total variance in non-diabetic and diabetic participants,
respectively.
In model 2, substituting T G and HDL-C with T G to
HDL-C ratio led to a single factor structure for both non-
diabetic and diabetic participants, which explained 47.6%
and 38.8% of variance, respectively (Table 3). HOMA-IR,
waist circumference and TG to HDL-C ratio had large
factor loadings on the selected factor of model 2 in both
diabetic and non-diabetic participants. However, in dia-
betic participants SBP had lower factor loading than did
other variables and thus was less correlated with the fac-
tor (Table 3).Esteghamati et al. Diabetology & Metabolic Syndrome 2010, 2:36
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Table 4 shows the association of factor scores with
MetS, defined by conventional criteria. In model 1, in
both non-diabetic and diabetic participants, factor 1 was
directly associated with MetS (odds ratio [OR]>1). Never-
theless, factor 2 and MetS were inversely correlated with
each other (OR<1). In model 2, the ORs (95% confidence
interval) for MetS defined by ATPIII, original IDF and
modified IDF were 9.9 (7.8-12.6), 8.4 (6.8-10.4) and 12.4
(9.5-16.0) in non-diabetic subjects and 5.8 (4.6-7.3), 4.4
(3.6-5.4) and 7.4 (5.8-9.4) in diabetic subjects, respec-
tively.
Discussion
Factor analysis of components revealed two factors in
model 1. In diabetic participants the first factor was
related to waist circumference, HOMA-IR and SBP while
in non-diabetic participants it was also associated with
TG. The second factor was determined positively by
HDL-C and negatively by TG. Factor 1 and 2 were
directly and inversely associated with MetS, respectively.
When TG and HDL-C were replaced by a composite
measure, which included both of them (i.e. TG to HDL-C
ratio), one factor was found, confirming previous obser-
vations on the monofactorial structure of MetS [23]. Fur-
thermore, these findings are consistent with the concept
that using two or more measures for the same trait results
in an overfactored model.
As previously mentioned, variations in sample collec-
tion, number and nature of selected components and also
in methods used for interpretation of analysis preclude
formal direct comparisons, but an overview elucidates
some common patterns. In several previous studies insu-
lin resistance loaded on the same factor with measures of
obesity including weight, body mass index and waist cir-
cumference [2, 5-9, 11, 13]. Furthermore, measures of
obesity were more likely to belong to the first extracted
factor and to have the highest factor loadings [6-9, 13]. It
has been demonstrated that visceral fat via its tendency
to release free fatty acids, stimulates hepatic glucose pro-
duction and accentuates insulin resistance [24]. More-
Table 1: Principal Characteristics of the Participants (n = 2978).
Characteristic Men Women
Non-diabetic participants
(n = 397)
Diabetic participants
(n = 565)
Non-diabetic participants
(n = 1255)
Diabetic participants
(n = 761)
Age (years) 41.1 ± 0.7 53.8 ± 0.5* 40.0 ± 0.4 54.1 ± 0.4*
Waist circumference (cm) 93.2 ± 0.6 99.5 ± 0.4* 90.9 ± 0.4 97.9 ± 0.4*
Fasting plasma glucose (mg/dl) 90.1 ± 0.5 174.3 ± 2.5* 91.5 ± 0.3 171.8 ± 2.1*
Insulin (U/l) 8.1 ± 0.3 8.9 ± 0.2 9.2 ± 0.2 9.0 ± 0.2
HOMA-IR (units)a 1.8 ± 0.08 3.7 ± 0.11* 2.1 ± 0.04 3.7 ± 0.09*
TG (mg/dl) 162.2 ± 4.7 208.7 ± 6.8* 133.7 ± 2.1 198.8 ± 4.1*
HDL-C (mg/dl) 46.8 ± 0.6 42.1 ± 0.5* 50.9 ± 0.3 48.5 ± 0.4*
SBP (mmHg) 121.1 ± 0.8 127.8 ± 0.7* 115.2 ± 0.5 131.9 ± 0.7*
Abdominal obesity (%)b
ATP III 22.7 36.0* 54.0 80.7*
IDF 48.5 72.0* 78.6 95.8*
Modified IDF 58.8 85.7* 51.2 76.9*
TG ≥ 150 (%) 43.3 59.9* 33.7 65.8*
Low HDL-C (%)c 26.8 46.4* 46.0 57.6*
Elevated blood pressure (%)d 35.6 56.8* 27.4 65.7*
MetS (%)e
ATP III 23.0 67.6* 31.3 87.7*
IDF 28.1 66.1* 36.0 89.9*
Modified IDF 31.2 78.1* 26.8 72.9*
Variables are expressed as percentage or mean ± SEM
* P <0.001 for the comparison of diabetic and non-diabetic participants. a Fasting insulin (U/l) × fasting plasma glucose (mg/dl)/405. b, c, d and e See 
text for definitions.
Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; SBP, 
systolic blood pressure; MetS, metabolic syndrome.Esteghamati et al. Diabetology & Metabolic Syndrome 2010, 2:36
http://www.dmsjournal.com/content/2/1/36
Page 5 of 8
over, visceral fat cells release some agents to the blood
(e.g. plasminogen activator inhibitor-1, interleukin-6 and
tumor necrosis factor-α) that are possibly linked to some
aspects of insulin resistance [24]. These interrelated
pathophysiologic mechanisms, underlying the associa-
tion of insulin resistance and obesity, may play a principal
role in the expression of MetS and its complications
including coronary heart disease and diabetes.
M e t S  i s  b e l i e v e d  t o  b e  r e l a t e d  t o  i n s u l i n  r e s i s t a n c e
which can be scored by measuring fasting insulin concen-
tration [1-3]. However, due to the fact that in diabetic
patients increase in blood glucose and insulin resistance
is accompanied by impaired insulin secretion [4], and
since there was no significant difference in fasting insulin
concentration between diabetic and non-diabetic partici-
pants (Table 1); fasting insulin is not a reliable index of
insulin resistance in diabetic patients. It has been demon-
strated that there is a good correlation between estimates
of insulin resistance derived from HOMA-IR and from
the euglycemic clamp [25]. Moreover HOMA-IR is a reli-
able index in diabetic patients and has been widely used
as an estimate of insulin resistance in both non-diabetic
and diabetic subjects [25,26]. Besides these advantages,
HOMA-IR has also some limitations. For instance, in
Korean population, the validity of HOMA-IR as a surro-
gate measure of insulin resistance in lean type 2 diabetic
subjects with the insulin secretory defect is disputed [27].
In model 1 of our analyses, HOMA-IR loaded primarily
on factor one, but the factor loading of HOMA-IR on fac-
tor 2 was -0.35 in non-diabetic participants which is close
to the loading threshold, |0.40|. Further, TG was associ-
ated with both extracted factors in non-diabetic partici-
pants (Figure 1). Many studies have used lower loading
thresholds or noted the effect of relaxing the threshold on
the findings [6,7,12,15]. Even Cureton and D'Agostino
suggested a loading threshold as low as 0.2 for factor
interpretation [28]. In model 1, association of HOMA-IR
and TG with both extracted factors in non-diabetic par-
ticipants shows that the two factors are related to each
other and are not totally independent. Consistent with
our findings, in most studies measures of insulin resis-
tance load on more than one factor, suggesting insulin
resistance as a unifying theme underlying the MetS [3].
On the other hand, Shen et al. found that TG and HDL-C
are part of the same risk component for MetS and inclu-
sion of both may be redundant [29]. In this regard, TG to
HDL-C ratio is reported to be helpful in determining risk
of coronary heart disease [30]. In model 2, substitution of
TG and HDL-C with TG to HDL-C ratio led to extraction
of just one factor. Mannucci et al. reported similar results
and revealed that considering TG and HDL-C as two dif-
ferent components of MetS results in overestimation of
the role of dyslipidaemia in MetS [5]. These findings sug-
gest that the model 2 of our analyses (one-factor model)
Table 2: Correlation coefficients between variables associated with metabolic syndrome in non-diabetic (n = 1652) and 
diabetic (n= 1326) participants.
Variable Waist circumference HOMA-IRa TG HDL-C TG/HDL-C
Non-diabetic participants
HOMA-IRa, b 0.44**
TGb 0.35** 0.27**
HDL-C -0.13** -0.14** -0.28**
TG/HDL-Cb 0.34** 0.28** 0.93** -0.61**
SBP 0.37** 0.11** 0.27** 0.01 0.22**
Diabetic participants
HOMA-IRa, b 0.36**
TGb 0.18** 0.25**
HDL-C -0.08* -0.11** -0.31**
TG/HDL-Cb 0.18** 0.24** 0.93** -0.63**
SBP 0.09* 0.05 0.03 0.05 0.01
* P <0.01; **P <0.001. a Fasting insulin (U/l) × fasting glucose (mg/dl)/405. b Log transformed.
Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; 
TG/HDL-C, triglycerides to HDL-C ratio; SBP, systolic blood pressure.Esteghamati et al. Diabetology & Metabolic Syndrome 2010, 2:36
http://www.dmsjournal.com/content/2/1/36
Page 6 of 8
is also plausible and support previous studies suggesting
one underlying factor (perhaps insulin resistance) for the
syndrome [23], the point which is recently substantiated
in experimental studies [31].
Insulin resistance and hyperinsulinemia lead to hyper-
tension via a number of mechanisms, including renal
sodium and water retention, rennin-angiotensin-aldos-
terone system, plasma noradrenaline and sympathetic
nervous system activity [32,33]. Since subjects' age range
is wide (18-75 years) it is more conceivable to use just
SBP instead of mean arterial pressure [34]. In model 2,
the factor loading of SBP was lowest among components
of MetS implying it as the most tenuously linked compo-
nent. Review of previous studies shows that in most anal-
yses measures of blood pressure load on a unique and
separate factor, which does not overlap with other factors
Table 3: Factor loadings of variables on the selected factors of Model 1 and 2, in diabetic and non-diabetic participants.
Variable Non-diabetic participants
(n = 1652)
Diabetic participants
(n = 1326)
Model 1a Factor 1 Factor 2 Factor 1 Factor 2
Waist circumference 0.80* -0.14 0.76* -0.12
HOMA-IRb 0.56* -0.35 0.71* -0.25
TGb 0.57* -0.46* 0.31 -0.69*
HDL-C 0.00 0.89* 0.03 0.81*
SBP 0.75* 0.29 0.50* 0.36
% Total variance explained 36.8 24.5 28.6 26.8
Model 2 Factor 1 Factor 1
Waist circumference 0.82* 0.74*
HOMA-IRb 0.68* 0.77*
TG/HDL-Cb 0.66* 0.59*
SBP 0.58* 0.21
% total variance explained 47.6 38.8
Factors with an eigenvalue ≥ 1 were selected for analysis. * Factor loadings ≥ |0.40|. a Factor loadings are calculated after varimax rotation of 
variables in each extracted factor. b Log transformed.
Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; 
TG/HDL-C, triglycerides to HDL-C ratio; SBP, systolic blood pressure.
Figure 1 Factor structure of metabolic syndrome in diabetic and non-diabetic participants due to model 1. Large circles correspond to factors 
and small circles to variables. Only the variables with factor loadings ≥|0.40| were selected. Abbreviations: HOMA-IR, homeostasis model assessment 
of insulin resistance; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; SBP, systolic blood pressure.Esteghamati et al. Diabetology & Metabolic Syndrome 2010, 2:36
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of MetS [2,9,11-13], revealing weak relation between
blood pressure and other components of MetS [3,29].
Even, such relation may not be evident in some ethnic
groups like American Indians and African Americans
[14]. Moreover, we found that SBP is less correlated with
components of MetS especially in diabetic subjects (Table
2). These findings suggest that blood pressure is less
influenced by the common pathophysiologic pathway
which underlies the MetS.
Ethnic differences in the expression of MetS are linked
to different appropriate waist circumference cut-offs for
determination of abdominal obesity. It has been found
that Asians in comparison to Caucasians are more prone
to obesity related comorbidities even at lower waist cir-
cumference values [35]. W e recently showed that waist
circumference cut-offs recommended by IDF are not
appropriate in Iranian population and should change to
90 cm in both men and women [18]. In this study we
found that IDF definition modified by our recommended
waist circumference cut-offs is strongly associated with
extracted factors. As table 4 shows, factor 2 was inversely
associated with MetS and therefore had protective roles
against it, which seems reasonable because factor 2 was
mainly characterized by significant positive factor load-
ing for HDL-C.
The major limitation, relevant to our results interpreta-
tion, is use of cross-sectional data. However, consistent
with our analysis most previous studies have used cross-
sectional study design to evaluate the interrelatedness of
MetS components. Cross-sectional analyses provides
information at a single point in time, nevertheless pro-
gressive and reciprocal mechanisms are likely to be
involved in the appearance of MetS. Therefore, longitudi-
nal studies are suggested to improve better our under-
standing of MetS.
Conclusions
This study revealed that in both diabetic and non-dia-
betic individuals the concept of a single underlying factor
(pathophysiologic pathway) for the expression of MetS is
plausible. Further, we showed that similar to ATPIII and
original IDF definitions; modified IDF definition is also
strongly associated with identified factors. Nevertheless,
among components of MetS blood pressure is less influ-
enced by the common factor and could be also mediated
by other pathophysiologic processes.
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